Company: LHI
Filing Date: 2025-02-14
Form Type: DRS/A
Source: 0001213900-25-014190
Chunk: 249

Company: Living Homeopathy International Ltd.
Filing Date: 2025-02-14
Form: DRS/A
Chunk 249
---
 and 50,000,000 Class B Ordinary Shares; and (ii) the par value of the shares decreased from $1 each to $0.0001 each (collectively refer as the “Share Re-classification”). One Class A Ordinary Share represents one voting right and one Class B Ordinary Share represents fifteen voting rights. The authorized share capital of the Company remained unchanged at $50,000. The 1 issued ordinary share held by LTO was reclassified as 10,000 Class A Ordinary Shares upon the Share Re-classification. The Company further allotted and issued 8,990,000 Class A Ordinary Shares at $899 and 1,000,000 Class B Ordinary Shares at $100, respectively to LTO. |

| (v) | On September 10, 2024, certain third parties, as strategic investors, acquired 4,320,000 Class A Ordinary Shares and 480,000 Class B Ordinary Shares, totaling 48% of total ordinary shares of the Company from LTO. |

The Company, together with its wholly-owned subsidiaries,
is effectively controlled by the same shareholder, Mr. To at 100% before the Reorganization and ultimately held as to 52% after the Reorganization.
As such, the Reorganization is considered as a recapitalization of entities under common control. The Company has retroactively restated
all shares and per share data for all the periods presented.

In accordance with the Financial Accounting Standards
Board (“FASB”) Accounting Standards Codification (“ASC”) 805-50-25, the Reorganization has been accounted for
as a recapitalization among entities under common control since the same shareholders controlled all these entities prior to and after
the Reorganization. The consolidation of the Company and its subsidiaries has been accounted for at historical cost and prepared on the
basis as if the aforementioned transactions had become effective as of the beginning of the first period presented in the accompanying
consolidated financial statements. The results of operations for the period presented comprise those of the previously separate entities
combined from the beginning of the period to the end of the period. By eliminating the effects of intra-entity transactions in determining
the results of operations for the period before the Reorganization, those results will be substantially the same as the results of operations
for the period after the date of Reorganization.

<div align='center'>F-7</div>

The effects of all inter-company transactions
are eliminated in consolidation. Furthermore, ASC 805-50-45-5